Medicaid Coverage for Continuous Glucose Monitors (SB 784)
March 13, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The bill aimed to expand access to diabetes management technology for Medicaid recipients by classifying CGMs as , which would have changed how providers are reimbursed for these devices.
Potentially affected actors named in the source documents. Mention is not a position.
Medicaid recipients
The bill would have expanded the types of medical equipment covered under their insurance program.
Durable medical equipment providers
The bill would have established new billing requirements and reimbursement pathways for these providers.
Last recorded activity March 13, 2026.
Introduced.
Summary
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
Did this bill become law?
How would providers have been paid for these monitors?
Why It Matters
The bill aimed to expand access to diabetes management technology for Medicaid recipients by classifying CGMs as , which would have changed how providers are reimbursed for these devices.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Billing Standardization
The bill explicitly sought to move CGM billing away from National Drug Code requirements toward the Medicare Healthcare Common Procedure Coding System.
Connected Entities
Sources
openstates.org
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy20Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools